Flow Traders U.S.’s Envoy Medical COCH Stock Holding History

Flow Traders U.S.’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,462	Closed	-$87K	–	847
2023 Q3	$87K	Buy	+12,462	New	+$125K	﹤0.01%	761

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Flow Traders U.S.'s COCH Position: Q4 2023 in Review

Flow Traders U.S. sold out of Envoy Medical (COCH) in Q4 2023, closing a stake of 12,462 shares — an estimated $87K sold.

Flow Traders U.S. first reported a position in COCH in Q3 2023 and held it in 1 quarter. The position peaked at $87K in Q3 2023. 9 funds tracked by Wall St. Rank hold COCH as of Q4 2023.

Flow Traders U.S. reported no remaining Envoy Medical position as of Q4 2023 after selling out during the quarter.
Flow Traders U.S. sold 12,462 Envoy Medical shares in Q4 2023, an estimated $87K.
Flow Traders U.S. first reported a position in Envoy Medical in Q3 2023 and held it in 1 quarter.
Flow Traders U.S.'s Envoy Medical position peaked at $87K in Q3 2023.
9 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2023.

Based on Flow Traders U.S.'s 13F filing for Q4 2023, filed 14 Feb 2024.